http://www.imim.cat/noticies Programa de recerca: Processos inflamatoris i cardiovasculars http://www.imim.cat/noticies/view.php?ID=766 <p>The <strong>Pharmacokinetics and Pharmacodynamics (PK/PD) Research Team</strong> at Hospital del Mar has <strong>received a competitive international grant</strong> awarded by the pharmaceutical company Pfizer, as part of the <em>&quot;Independent Research Grant Program - Pharmacokinetics-pharmacodynamics (PK/PD) of Aztreonam-Avibactam (ATM-AVI) in Special Populations.&quot;</em> The selected project, chosen among proposals from several European centers, aims to optimize the use of the new antibiotic aztreonam-avibactam in patients with renal impairment - a population particularly vulnerable to severe infections caused by multidrug-resistant bacteria. The project is led by Dr. Mila Montero and Dr. Sònia Luque.</p> 04/11/2025